Global Immunology Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
The immune system protects the body from harmful things such as a virus, germs, and diseases like cancer. It is a network of cells, molecules: and organs present throughout the body. The immune system attacks the foreign substance that is found in the body. The body identifies and destroys the abnormal cells including cancerous cells. The inherent self-defense system comprises cells, which help the body in the identification of foreign molecules. Different pathways regulate various immune cells for distinguishing body's healthy cells and disease-causing foreign agents such as a virus: parasite, bacteria, fungi, and cancerous cells. To maintain the body's defense against the continuously evolving organisms, which try to attack the body in numerous ways, continuous modification of all the components of the immune system is essential. Sometimes, the continuously modifying immune system reacts against the body's cells, considering them as foreign agents, which results in the destruction of healthy tissues and becomes the cause of autoimmune diseases and cancers. The inherent state of unresponsiveness may also be observed due to the weakened body defense owing to the genetic reasons that result in immunodeficiency disease.
Scope of the Report:
This report studies the Immunology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immunology market by product type and applications/end industries.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
The latest trend gaining momentum in the market is significant pipeline. There are multiple promising immunological agents in the pipeline, which boost the market growth after their approval. The approval of new therapeutic agents broadens the options available for the treatment and thus leads to the increase in demand for the therapeutic regimen. There are approximately 51 molecules under different clinical trial stages globally.
The global Immunology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immunology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
Scope of the Report:
This report studies the Immunology market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immunology market by product type and applications/end industries.
One of the major drivers for this market is growing cases of infectious diseases. Infectious diseases such as hepatitis and acquired immunodeficiency syndrome (AIDS) are rampant globally. When the body's immune system is unable to resist the invading pathogens or microbes, it gives way to infections. Infectious diseases such as hepatitis and AIDS can be treated by immunomodulators. Agents that help in boosting the immunity of the human body help in resisting pathogens. According to the CDC, there are more than a million AIDS-affected people in the US. With the rising incidences of infectious diseases, the demand for immunology products will increase in the following years.
The latest trend gaining momentum in the market is significant pipeline. There are multiple promising immunological agents in the pipeline, which boost the market growth after their approval. The approval of new therapeutic agents broadens the options available for the treatment and thus leads to the increase in demand for the therapeutic regimen. There are approximately 51 molecules under different clinical trial stages globally.
The global Immunology market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immunology.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- AbbVie
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Bionor Pharma
- Celgene
- Cellectar Biosciences
- eFFECTOR Therapeutics
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers
- Immuno Boosters
- Immunosuppressants
- Autoimmune Diseases
- Oncology
- Organ Transplantation
- Others
1 IMMUNOLOGY MARKET OVERVIEW
1.1 Product Overview and Scope of Immunology
1.2 Classification of Immunology by Types
1.2.1 Global Immunology Revenue Comparison by Types (2017-2023)
1.2.2 Global Immunology Revenue Market Share by Types in 2017
1.2.3 Immuno Boosters
1.2.4 Immunosuppressants
1.3 Global Immunology Market by Application
1.3.1 Global Immunology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Global Immunology Market by Regions
1.4.1 Global Immunology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Immunology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immunology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immunology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Immunology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immunology Status and Prospect (2013-2023)
1.5 Global Market Size of Immunology (2013-2023)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Immunology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Immunology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Immunology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Immunology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bionor Pharma
2.5.1 Business Overview
2.5.2 Immunology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bionor Pharma Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Celgene
2.6.1 Business Overview
2.6.2 Immunology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celgene Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cellectar Biosciences
2.7.1 Business Overview
2.7.2 Immunology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cellectar Biosciences Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.8 eFFECTOR Therapeutics
2.8.1 Business Overview
2.8.2 Immunology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 eFFECTOR Therapeutics Immunology Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IMMUNOLOGY MARKET COMPETITION, BY PLAYERS
3.1 Global Immunology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Immunology Players Market Share
3.2.2 Top 10 Immunology Players Market Share
3.3 Market Competition Trend
4 GLOBAL IMMUNOLOGY MARKET SIZE BY REGIONS
4.1 Global Immunology Revenue and Market Share by Regions
4.2 North America Immunology Revenue and Growth Rate (2013-2018)
4.3 Europe Immunology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Immunology Revenue and Growth Rate (2013-2018)
4.5 South America Immunology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Immunology Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA IMMUNOLOGY REVENUE BY COUNTRIES
5.1 North America Immunology Revenue by Countries (2013-2018)
5.2 USA Immunology Revenue and Growth Rate (2013-2018)
5.3 Canada Immunology Revenue and Growth Rate (2013-2018)
5.4 Mexico Immunology Revenue and Growth Rate (2013-2018)
6 EUROPE IMMUNOLOGY REVENUE BY COUNTRIES
6.1 Europe Immunology Revenue by Countries (2013-2018)
6.2 Germany Immunology Revenue and Growth Rate (2013-2018)
6.3 UK Immunology Revenue and Growth Rate (2013-2018)
6.4 France Immunology Revenue and Growth Rate (2013-2018)
6.5 Russia Immunology Revenue and Growth Rate (2013-2018)
6.6 Italy Immunology Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC IMMUNOLOGY REVENUE BY COUNTRIES
7.1 Asia-Pacific Immunology Revenue by Countries (2013-2018)
7.2 China Immunology Revenue and Growth Rate (2013-2018)
7.3 Japan Immunology Revenue and Growth Rate (2013-2018)
7.4 Korea Immunology Revenue and Growth Rate (2013-2018)
7.5 India Immunology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Immunology Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA IMMUNOLOGY REVENUE BY COUNTRIES
8.1 South America Immunology Revenue by Countries (2013-2018)
8.2 Brazil Immunology Revenue and Growth Rate (2013-2018)
8.3 Argentina Immunology Revenue and Growth Rate (2013-2018)
8.4 Colombia Immunology Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE IMMUNOLOGY BY COUNTRIES
9.1 Middle East and Africa Immunology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Immunology Revenue and Growth Rate (2013-2018)
9.3 UAE Immunology Revenue and Growth Rate (2013-2018)
9.4 Egypt Immunology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Immunology Revenue and Growth Rate (2013-2018)
9.6 South Africa Immunology Revenue and Growth Rate (2013-2018)
10 GLOBAL IMMUNOLOGY MARKET SEGMENT BY TYPE
10.1 Global Immunology Revenue and Market Share by Type (2013-2018)
10.2 Global Immunology Market Forecast by Type (2018-2023)
10.3 Immuno Boosters Revenue Growth Rate (2013-2023)
10.4 Immunosuppressants Revenue Growth Rate (2013-2023)
11 GLOBAL IMMUNOLOGY MARKET SEGMENT BY APPLICATION
11.1 Global Immunology Revenue Market Share by Application (2013-2018)
11.2 Immunology Market Forecast by Application (2018-2023)
11.3 Autoimmune Diseases Revenue Growth (2013-2018)
11.4 Oncology Revenue Growth (2013-2018)
11.5 Organ Transplantation Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 GLOBAL IMMUNOLOGY MARKET SIZE FORECAST (2018-2023)
12.1 Global Immunology Market Size Forecast (2018-2023)
12.2 Global Immunology Market Forecast by Regions (2018-2023)
12.3 North America Immunology Revenue Market Forecast (2018-2023)
12.4 Europe Immunology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Immunology Revenue Market Forecast (2018-2023)
12.6 South America Immunology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Immunology Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Immunology
1.2 Classification of Immunology by Types
1.2.1 Global Immunology Revenue Comparison by Types (2017-2023)
1.2.2 Global Immunology Revenue Market Share by Types in 2017
1.2.3 Immuno Boosters
1.2.4 Immunosuppressants
1.3 Global Immunology Market by Application
1.3.1 Global Immunology Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Global Immunology Market by Regions
1.4.1 Global Immunology Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Immunology Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immunology Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immunology Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Immunology Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immunology Status and Prospect (2013-2023)
1.5 Global Market Size of Immunology (2013-2023)
2 MANUFACTURERS PROFILES
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Immunology Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Immunology Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche
2.3.1 Business Overview
2.3.2 Immunology Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Immunology Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bionor Pharma
2.5.1 Business Overview
2.5.2 Immunology Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bionor Pharma Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.6 Celgene
2.6.1 Business Overview
2.6.2 Immunology Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Celgene Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cellectar Biosciences
2.7.1 Business Overview
2.7.2 Immunology Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cellectar Biosciences Immunology Revenue, Gross Margin and Market Share (2016-2017)
2.8 eFFECTOR Therapeutics
2.8.1 Business Overview
2.8.2 Immunology Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 eFFECTOR Therapeutics Immunology Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL IMMUNOLOGY MARKET COMPETITION, BY PLAYERS
3.1 Global Immunology Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Immunology Players Market Share
3.2.2 Top 10 Immunology Players Market Share
3.3 Market Competition Trend
4 GLOBAL IMMUNOLOGY MARKET SIZE BY REGIONS
4.1 Global Immunology Revenue and Market Share by Regions
4.2 North America Immunology Revenue and Growth Rate (2013-2018)
4.3 Europe Immunology Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Immunology Revenue and Growth Rate (2013-2018)
4.5 South America Immunology Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Immunology Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA IMMUNOLOGY REVENUE BY COUNTRIES
5.1 North America Immunology Revenue by Countries (2013-2018)
5.2 USA Immunology Revenue and Growth Rate (2013-2018)
5.3 Canada Immunology Revenue and Growth Rate (2013-2018)
5.4 Mexico Immunology Revenue and Growth Rate (2013-2018)
6 EUROPE IMMUNOLOGY REVENUE BY COUNTRIES
6.1 Europe Immunology Revenue by Countries (2013-2018)
6.2 Germany Immunology Revenue and Growth Rate (2013-2018)
6.3 UK Immunology Revenue and Growth Rate (2013-2018)
6.4 France Immunology Revenue and Growth Rate (2013-2018)
6.5 Russia Immunology Revenue and Growth Rate (2013-2018)
6.6 Italy Immunology Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC IMMUNOLOGY REVENUE BY COUNTRIES
7.1 Asia-Pacific Immunology Revenue by Countries (2013-2018)
7.2 China Immunology Revenue and Growth Rate (2013-2018)
7.3 Japan Immunology Revenue and Growth Rate (2013-2018)
7.4 Korea Immunology Revenue and Growth Rate (2013-2018)
7.5 India Immunology Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Immunology Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA IMMUNOLOGY REVENUE BY COUNTRIES
8.1 South America Immunology Revenue by Countries (2013-2018)
8.2 Brazil Immunology Revenue and Growth Rate (2013-2018)
8.3 Argentina Immunology Revenue and Growth Rate (2013-2018)
8.4 Colombia Immunology Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE IMMUNOLOGY BY COUNTRIES
9.1 Middle East and Africa Immunology Revenue by Countries (2013-2018)
9.2 Saudi Arabia Immunology Revenue and Growth Rate (2013-2018)
9.3 UAE Immunology Revenue and Growth Rate (2013-2018)
9.4 Egypt Immunology Revenue and Growth Rate (2013-2018)
9.5 Nigeria Immunology Revenue and Growth Rate (2013-2018)
9.6 South Africa Immunology Revenue and Growth Rate (2013-2018)
10 GLOBAL IMMUNOLOGY MARKET SEGMENT BY TYPE
10.1 Global Immunology Revenue and Market Share by Type (2013-2018)
10.2 Global Immunology Market Forecast by Type (2018-2023)
10.3 Immuno Boosters Revenue Growth Rate (2013-2023)
10.4 Immunosuppressants Revenue Growth Rate (2013-2023)
11 GLOBAL IMMUNOLOGY MARKET SEGMENT BY APPLICATION
11.1 Global Immunology Revenue Market Share by Application (2013-2018)
11.2 Immunology Market Forecast by Application (2018-2023)
11.3 Autoimmune Diseases Revenue Growth (2013-2018)
11.4 Oncology Revenue Growth (2013-2018)
11.5 Organ Transplantation Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 GLOBAL IMMUNOLOGY MARKET SIZE FORECAST (2018-2023)
12.1 Global Immunology Market Size Forecast (2018-2023)
12.2 Global Immunology Market Forecast by Regions (2018-2023)
12.3 North America Immunology Revenue Market Forecast (2018-2023)
12.4 Europe Immunology Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Immunology Revenue Market Forecast (2018-2023)
12.6 South America Immunology Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Immunology Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Immunology Picture
Table Product Specifications of Immunology
Table Global Immunology and Revenue (Million USD) Market Split by Product Type
Figure Global Immunology Revenue Market Share b
Figure Immunology Picture
Table Product Specifications of Immunology
Table Global Immunology and Revenue (Million USD) Market Split by Product Type
Figure Global Immunology Revenue Market Share b
